Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.74 |
| ▸ | LMNA | P02545 | 1/20 | 0.74 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.74 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | MGAM | O43451 | 1/20 | 0.42 |
| ▸ | SI | P14410 | 1/20 | 0.42 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.42 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 3/20 | 0.39 |
| ▸ | CA1 | P00915 | 3/20 | 0.39 |
| ▸ | CA2 | P00918 | 3/20 | 0.39 |
| ▸ | CA9 | Q16790 | 3/20 | 0.39 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.38 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.38 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.37 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethyl Acetate SCHEMBL5861342 | 1.00 | ALDH1A1 (0.74) | ALDH1A1LMNAHSD17B10TSHRTRPA1 | |
| Ethyl Acetate SCHEMBL6046507 | 1.00 | ALDH1A1 (0.74) | ALDH1A1LMNAHSD17B10TSHRTRPA1 | |
| Ethyl Acetate SCHEMBL6347449 | 1.00 | ALDH1A1 (0.74) | ALDH1A1LMNAHSD17B10TSHRTRPA1 | |
| Ethyl Acetate SCHEMBL11579143 | 0.97 | ALDH1A1 (0.70) | ALDH1A1LMNAHSD17B10TSHRTRPA1 | |
| Ethyl Acetate SCHEMBL6252701 | 0.97 | ALDH1A1 (0.70) | ALDH1A1LMNAHSD17B10TSHRTRPA1 | |
| Ethyl Acetate SCHEMBL882 | 0.97 | ALDH1A1 (0.70) | ALDH1A1LMNAHSD17B10TSHRTRPA1 | |
| Ethyl Acetate SCHEMBL3507062 | 0.97 | ALDH1A1 (0.70) | ALDH1A1LMNAHSD17B10TSHRTRPA1 | |
| Ethyl Acetate SCHEMBL11069490 | 0.95 | ALDH1A1 (0.67) | ALDH1A1LMNAHSD17B10TSHRTRPA1 | |
| Ethyl Acetate SCHEMBL1399223 | 0.95 | ALDH1A1 (0.67) | ALDH1A1LMNAHSD17B10TSHRTRPA1 | |
| Ethyl Acetate SCHEMBL1552436 | 0.95 | ALDH1A1 (0.67) | ALDH1A1LMNAHSD17B10TSHRTRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 822 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117447489-A | Synthesis method of cefmetazole impurity | 山东安弘制药有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-115895426-A | Water-based polyurethane waterproof paint | 宁国申华防水材料有限公司 | 2023-04-04 | — | — | CN | claimed |
| CN-103387531-A | Amide arylpiperazine derivatives, their preparation method, and their application in benign prostatic hyperplasia resistance | UNIV GUANGZHOU MEDICAL | 2013-11-13 | — | — | CN | claimed |
| WO-2024240101-A9 | GALNAC COMPOUND, CONJUGATE, COMPOSITION, AND USE THEREOF | 北京炫景瑞医药科技有限公司 | 2025-03-06 | — | — | WO | disclosed |
| CN-119524213-A | Antibacterial coating, preparation method and application thereof, and medical instrument | 青岛科技大学 | 2025-02-28 | — | — | CN | disclosed |
| WO-2024240101-A1 | GALNAC COMPOUND, CONJUGATE, COMPOSITION, AND USE THEREOF | 北京炫景瑞医药科技有限公司 | 2024-11-28 | — | — | WO | disclosed |
| CN-118742570-A | Anti-ALK 1 antibodies and methods of use thereof | 吉诺瓦克抗体发现有限责任公司 | 2024-10-01 | — | — | CN | disclosed |
| US-12018029-B2 | Hexahydropyrrolo[3,4-c]pyrrole derivatives useful as LOX inhibitors | THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) | 2024-06-25 | — | — | US | disclosed |
| EP-4370497-A1 | SEROTONIN 5-HT2A, 5-HT2B, AND 5-HT2C RECEPTOR INVERSE AGONISTS | Northeastern University (US) | 2024-05-22 | — | — | EP | disclosed |
| CN-117269403-B | Thin-layer identification method of medicinal material Zanthoxylum bungeanum in Chinese medicinal composition containing Zanthoxylum bungeanum | 湖南易能生物医药有限公司 | 2024-04-26 | — | — | CN | disclosed |
| EP-4349846-A1 | CHIMERIC NUCLEIC ACID OLIGOMER INCLUDING PHOSPHOROTHIOATE AND BORANOPHOSPHATE, AND METHOD FOR PRODUCING SAME | TOKYO UNIVERSITY OF SCIENCE FOUNDATION (JP) | 2024-04-10 | — | — | EP | disclosed |
| US-4265891-A | PROSTAGLANDINS, BRONCHODILATORS, PLATELET AGGREGATION INHIBITORS | GLAXO GROUP LIMITED (GB) | 1981-05-05 | — | — | US | disclosed |
| EP-0022080-A1 | Synthetic polymer compositions containing triazine derivatives as light stabilizers and novel triazine derivatives | SANKYO COMPANY LIMITED (JP) | 1981-01-07 | — | — | EP | disclosed |
| US-4205070-A | ANTIBIOTICS | ABBOTT LABORATORIES (US) | 1980-05-27 | — | — | US | disclosed |
| US-4196197-A | 2'N-Acyl and alkyl-6'-N-alkyl- and 6',6'-di-N-alkyl derivatives of fortimicins A and B | ABBOTT LABORATORIES (US) | 1980-04-01 | — | — | US | disclosed |
| US-4177292-A | ANOREXIGENIC AGENTS, ANTIDEPRESSANTS | ROUSSEL UCLAF (FR) | 1979-12-04 | — | — | US | disclosed |
| EP-0000769-A2 | Polymers containing polyalkylpiperidines and use thereof as stabilizers | SANKYO COMPANY LIMITED (JP) | 1979-02-21 | — | — | EP | disclosed |
| US-4117164-A | ANTIDEPRESSANTS | ROUSSEL UCLAF (FR) | 1978-09-26 | — | — | US | disclosed |
| US-3950527-A | SEDATIVES | ROUSSEL-UCLAF (FR) | 1976-04-13 | — | — | US | disclosed |
| US-3932643-A | INTERFERON INDUCERS | PFIZER INC. (US) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12018029-B2 | Hexahydropyrrolo[3,4-c]pyrrole derivatives useful as LOX inhibitors | LOX, LOXL1, LOXL3 | ALDH1A1 765/4885LMNA 983/4885HSD17B10 2869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.